Western States Node and CTN Grieve Loss of Mitch Greenlick |
SHARE ISSUE ON |

|
|
The Western States Node and the CTN lost one of the founding Principal Investigators with the death of Merwyn (Mitch) Greenlick on Friday May 15, 2020 from natural causes. He was 85 years of age and had dealt with multiple health problems in the past year.
Dr. Greenlick, a member of the Oregon House of Representatives (2003 - 2020) served for many years as the Chair of the House Health Care Committee sponsoring and passing progressive legislation that enhanced access to healthcare for many Oregonians. The Willamette Weekly noted, "Greenlick was famed in the Legislature for his utter lack of bedside manner—he suffered fools tartly, if at all."
His traits and skills shaped health care and research in the Kaiser Permanente Health Care Systems and the National Drug Abuse Treatment Clinical Trials Network. He leaves a unique legacy and will be missed. We are all better and have learned from his guidance, wisdom and grit.
Betty Tai Director for the Center for the Clinical Trials Network reflected, "Upon the CTN’s creation, Mitch’s big voice and warm heart were critical components of our steering committee. ". . . My fondest memories of Mitch are of his passion, his energy, and his tireless commitment to the wellbeing of the most underserved populations. I miss him a lot and feel a great sense of loss. Mitch, I hope you rest peacefully. You have done so much and we would not be here if it weren’t for you. There is still much more to do and we will continue to carry on the mission."
Read more from the Western States Node's tribute to Dr. Greenlick here. |
CTN Trial Progress
Randomizations for Active Studies as of the June 14, 2020 trial Progress Report.
CTN-0069 - OUD in the Emergency Department. Enrolled 739
Total randomizations in active trials: 739
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
New in the CTN Dissemination Library
Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD. Morgan-Lopez AA, et al. Journal of Affective Disorders 2020;274:832-840.
Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use. Hatch-Maillette MA, et al. Journal of Substance Abuse Treatment 2020;116:108043 (in press).
Hispanic participants in the National Institute on Drug Abuse's Clinical Trials Network: A scoping review of two decades of research. Eghaneyan BH, et al. Addictive Behaviors Reports 2020 (in press).
Secondary analysis of pain outcomes in a large pragmatic randomized trial of buprenorphine/naloxone versus methadone for opioid use disorder. Shulman M, et al. Journal of Addiction Medicine 2020 (in press).
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
News from the Nodes
Northeast Node
On February 13, 2020, Dr. Susanne Tanski presented for the Northeast Node’s Science Series on the status of vaping in 2020, including the variability of devices and substances used, the health risks of vaping devices and the current policies, and recommendations for addressing youth and adult e-cigarette use.
Dr. Tanski is the Section Chief of General Pediatrics at the Children’s Hospital at Dartmouth (CHaD) and Associate Professor of Pediatrics at the Geisel School of Medicine at Dartmouth.
In her presentation, Dr. Tanski detailed that the harm of these products does not only depend on the drug being inhaled, but also the delivery device. Depending on the device and model, smoking one pod could be the equivalent of smoking 20-100 cigarettes.
As a pediatrician, Dr. Tanski has had first-hand experience seeing youth using e-cigarettes and vaping products. In her presentation Dr. Tanski discussed the surge in use among adolescents and how it can be attributed to a variety of factors, including advertisements targeted for youth, flavorings of interest to youth, and underlying nicotine to create dependence.
Dr. Tanski’s current research endeavors focus on tobacco use in adolescents and young adults, media influences on adolescent smoking and drinking, communication between pediatric clinicians and parents regarding eliminating secondhand smoke exposure of children and helping parents promote healthy lifestyles for their children.
You can view Dr. Tanski’s Science Series presentation here, as well as previously archived presentations. |
Southwest Node
Casa de Salud, a nonprofit clinic in Albuquerque, NM and one of the community treatment programs in the CTN’s Southwest Node, was recently the focus of an NPR article about the struggle for COVID-19 relief funding experienced by Medicaid clinics.
Most of the $100 billion authorized by Congress for health care providers has gone to hospitals, doctors, and other facilities that serve Medicare patients. That approach has left out a large swath of the health system infrastructure that serves low-income Medicaid populations and children. Case de Salud, for example, accepts Medicaid but not Medicare. State Medicaid directors say that without immediate funding, many of the health facilities that serve Medicaid patients could close permanently. Read the full article here.
· · · · · · · · · · · · · · · · · · · · · · · · · · · ·
Protocol Updates
CTN-0100
We are excited that the Data Management meeting for CTN-0100 is underway, occurring remotely the week of June 1st, during which we will review final study assessments and operating procedures. We continue to consider how much of the study can be conducted and managed remotely. National calls are planned for Tuesdays at 1pm ET and Clinical calls for Tuesdays at 3pm ET. We are waiting for final approval from Braeburn to establish a start date for Wave 1. For more information, please contact RDD at rdd@nyulangone.org.
CTN-0096
NIH recently featured a piece in their Research Spotlights blog about CTN-0096, an NIH HEAL Initiative study that will develop and test a culturally-centered program to support the integration of medications to treat OUD among AI/AN populations in primary care and addiction treatment clinics. Find the article here! |
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Also of Interest
CTN Node Information Updated for 2020
Find information about the 2020 CTN Nodes (16 total) at the CTN Dissemination Library website!
NIH Notice of Intent to Publish Four Funding Opportunity Announcements as part of the RADx-UP Initiative
On Friday, NIH issued a Notice of Intent to Publish (NOITP) four Funding Opportunity Announcements as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, a $500 million initiative to reduce COVID-19 associated morbidity and mortality disparities for vulnerable and underserved populations that are disproportionately affected by COVID-19. The FOAs, in which NIDA will be participating, will include three Notices of Special Interest to solicit community-engaged research to understand COVID-19 disparities and increase access to and effectiveness of diagnostic testing interventions among underserved and vulnerable populations, and to understand the social, ethical, and behavioral implications of testing in these populations. An RFA to support a Coordination and Data Collection Center (CDCC) will also be announced.
The FOAs are expected to be published in early June. Applications will be accepted through August 2020 for FY20 funding.
|